A Phase 3 Clinical Study of KW-3357 in Patients With DIC
Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of KW-3357 with concomitant use of heparin using
multi-center, non-comparative, open-label method in patients diagnosed as disseminated
intravascular coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC
criteria.
Phase:
Phase 3
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited Kyowa Kirin Co., Ltd.